Cargando…

Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease

SerpinA1 (α1-antitrypsin) is a soluble glycoprotein, the cerebrospinal fluid (CSF) isoforms of which showed disease-specific changes in neurodegenerative disorders that are still unexplored in Alz-heimer’s disease (AD). By means of capillary isoelectric focusing immunoassay, we investigated six serp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barba, Lorenzo, Halbgebauer, Steffen, Paolini Paoletti, Federico, Bellomo, Giovanni, Abu-Rumeileh, Samir, Steinacker, Petra, Massa, Federico, Parnetti, Lucilla, Otto, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266332/ https://www.ncbi.nlm.nih.gov/pubmed/35805926 http://dx.doi.org/10.3390/ijms23136922

Ejemplares similares

CSF SerpinA1 in Creutzfeldt–Jakob disease and frontotemporal lobar degeneration
por: Abu‐Rumeileh, Samir, et al.
Publicado: (2020)

Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease
por: Barschke, Peggy, et al.
Publicado: (2022)

Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
por: Barba, Lorenzo, et al.
Publicado: (2022)

Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data
por: Halbgebauer, Steffen, et al.
Publicado: (2016)

High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease
por: Abu‐Rumeileh, Samir, et al.
Publicado: (2023)

A/T/(N) Profile in Cerebrospinal Fluid of Parkinson’s Disease with/without Cognitive Impairment and Dementia with Lewy Bodies
por: Bellomo, Giovanni, et al.
Publicado: (2020)

CSF Ubiquitin Levels Are Higher in Alzheimer’s Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
por: Bellomo, Giovanni, et al.
Publicado: (2021)

Plasma β‐synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy
por: Abu‐Rumeileh, Samir, et al.
Publicado: (2023)

The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers
por: Paolini Paoletti, Federico, et al.
Publicado: (2020)

Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
por: Bellomo, Giovanni, et al.
Publicado: (2020)

Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt–Jakob Disease
por: Abu-Rumeileh, Samir, et al.
Publicado: (2022)

Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration
por: Gómez de San José, Nerea, et al.
Publicado: (2021)

Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers
por: Farotti, Lucia, et al.
Publicado: (2020)

The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis
por: Paolini Paoletti, Federico, et al.
Publicado: (2021)

In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis
por: Bezerra, Filipa, et al.
Publicado: (2021)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer’s Disease: ELISA Development and Clinical Validation
por: Wojdała, Anna Lidia, et al.
Publicado: (2022)

Cirrhosis of liver: Interference of serpins in quantification of SERPINA4 – A preliminary study
por: Nallagangula, Krishna Sumanth, et al.
Publicado: (2017)

Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia
por: Jesse, Sarah, et al.
Publicado: (2012)

Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancer
por: Kwon, Chae Hwa, et al.
Publicado: (2015)

SerpinA3N attenuates ischemic stroke injury by reducing apoptosis and neuroinflammation
por: Zhang, Yu, et al.
Publicado: (2021)

SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury
por: González-Soria, Isaac, et al.
Publicado: (2023)

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
por: Eusebi, Paolo, et al.
Publicado: (2018)

Cerebrospinal Fluid and Blood Neurofilament Light Chain Protein in Prion Disease and Other Rapidly Progressive Dementias: Current State of the Art
por: Abu-Rumeileh, Samir, et al.
Publicado: (2021)

Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke
por: Barba, Lorenzo, et al.
Publicado: (2023)

Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Issue of Diurnal Variation
por: Cicognola, Claudia, et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers and Prediction of Conversion in Patients with Mild Cognitive Impairment: 4-Year Follow-Up in a Routine Clinical Setting
por: Lanari, Alessia, et al.
Publicado: (2009)

SerpinA3N deficiency deteriorates impairments of learning and memory in mice following hippocampal stab injury
por: Wang, Zhi-Meng, et al.
Publicado: (2020)

IFN-Inducible SerpinA5 Triggers Antiviral Immunity by Regulating STAT1 Phosphorylation and Nuclear Translocation
por: Wang, Congcong, et al.
Publicado: (2023)

An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders
por: Tambasco, Nicola, et al.
Publicado: (2022)

The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase
por: Vicuña, Lucas, et al.
Publicado: (2015)

SerpinA3N is a novel hypothalamic gene upregulated by a high-fat diet and leptin in mice
por: Sergi, Domenico, et al.
Publicado: (2018)

Plasma SerpinA5 in conjunction with uterine artery pulsatility index and clinical risk factor for the early prediction of preeclampsia
por: Zhang, Yonggang, et al.
Publicado: (2021)

Editorial: CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases
por: Foschi, Matteo, et al.
Publicado: (2023)

Potential impact of serpin peptidase inhibitor clade (A) member 4 SERPINA4 (rs2093266) and SERPINA5 (rs1955656) genetic variants on COVID-19 induced acute kidney injury
por: El-Hefnawy, Sally M., et al.
Publicado: (2022)

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
por: Luo, Dingyuan, et al.
Publicado: (2017)

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers
por: Gaetani, Lorenzo, et al.
Publicado: (2020)

PEG-J replacement for duodenal levodopa infusion in Parkinson’s disease patients: a retrospective study
por: Simoni, Simone, et al.
Publicado: (2022)

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia
por: Spitzer, Philipp, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0pclf0mlksauv49724nh6h5nj3